The GOLD Podcast: Weekly Pharma Insights EMJ

Join Isabel and Jade for this special episode of the GOLD podcast as three of last year's guests share their predictions for the pharmaceutical industry in 2024. The panel includes Matt Lewis from Inizio, Rick Hollis from Ipsen and Claudia Martinez from the Access to Medicine Foundation, all of whom share their predictions in their areas of expertise.

But that's not all. The GOLD hosts also reminisce about the team's 2023 predictions podcast to see if these guests could really see the future.

The Season 6 finale of the GOLD podcast has landed! Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals. 
In this episode, Kinnari shares her thoughts on how the industry can engage the next generation of scientific leaders to propel itself into the future. Tune in to find out what might be stopping the younger generation from pursuing a career in pharma and how the industry can work to change their minds, the benefits of a more diverse workforce, the future of drug development and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 
Mastering medical affairs

Taking women to the top of pharma

Do happy employees equal better innovation?

Last week's podcast: A patient's right to thrive, not just survive

Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Going for gold in gynaecological cancers Mental health matters in pharma's approach to care Last week's podcast: What motivates and challenges GOLD's guests?

For each episode of Season 6, the GOLD team has asked its podcast guests to reflect on the same question: what gets you up in the morning, and what keeps you up at night?

 
As Season 6 nears its close, Isabel brings you a curated selection of insights from the leaders we have heard from so far. Tune in to find out what motivates these pharma aficionados and what they see as the key challenges in the industry today.

 
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

GOLD's latest roundtable: Was it worth the risk?
Last week's episode: Meet GOLD's latest Catalyst - Roche’s Dr Peter Ahnesorg

"}}},"VERSION":"9.14.7"}"> Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.

 

In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader today.
 
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Podcast: Changing the tide on health inequities
Podcast: Do happy employees equal better innovation?
Last week’s podcast: A high-speed chase for oncology innovation

Tune in to the latest episode of the GOLD podcast as Isabel and Jade present a discussion with Jaime Manzanera Gómez, EMEA Brand Director, Oncology, Eisai, who details how oncology teams can best increase the pace of innovation in the field.
In this episode, Jaime shares his thoughts on the pace of innovation after the heights of COVID-19, how regulatory constraints can sometimes affect the industry's thirst for innovation, his passion for the outdoors and much more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  
Do happy employees equal better innovation? Going for gold in gynaecological cancers Last week's podcast: Changing the tide on health inequities